Features of age-related macular degeneration assessed with three-dimensional Fourier-domain optical coherence tomography

British Journal of Ophthalmology

Volumn 92, Issue 11, 2008, Pages 1492-1497

  Menke, M N ^a   Dabov, S ^b   Sturm, V ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; B SCAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MORPHOLOGY; HUMAN; IMAGE QUALITY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOURIER ANALYSIS; HUMANS; IMAGING, THREE-DIMENSIONAL; MACULA LUTEA; MACULAR DEGENERATION; OPTIC DISK; PHOTORECEPTOR CELLS, VERTEBRATE; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 55449130130     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.141242     Document Type: Article

References (25)

1. Evans J. Causes of blindness and partial sight in England and Wales 1990-1991. Studies on medical and population subjects 57. London: HSMO, 1995.
2. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
3. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995;113:325-32.
4. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217-29.
5. Choma MA, Sarunic MV, Yang C, et al. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express 2003;11:2183-9.
6. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005;112:1734-46.
7. Wojtkowski M, Srinivasan V, Ko T, et al. Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express 2004;12:2404- 22.
8. Wojtkowski M, Srinivasan V, Ko T, et al. High speed, ultrahigh resolution retinal imaging using spectral/Fourier domain OCT. Conf Lasers Electrooptics 2005;3:2058-60.
9. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularisation. Ophthalmology 1996;103:1260-70.
10. Spraul CW, Lang GE, Lang GK. Value of optical coherence tomography in diagnosis of age-related macular degeneration. Correlation of fluorescein angiography and OCT findings. Klin Monatsbl Augenheilkd 1998;212:141-8.
11. Giovannini A, Amato GP, Mariotti C, et al. OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery. Br J Ophthalmol 1999;83:438-42.
12. Van Kerckhoven W, Lafaut B, Follens I, et al. Features of age-related macular degeneration on optical coherence tomography. Bull Soc Belge Ophthalmol 2001;281:75-84.
13. Eter N, Bindewald A, Roth F, et al. OCT in age-related macular degeneration. Findings, usage in clinical routine, and assessment of treatment outcome. Ophthalmologe 2004;101:794-803.
14. Ting TD, Oh M, Cox TA, et al. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 2002;120:731-7.
15. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularisation. Retina 2003;23:159-65.
16. Rogers AH, Martidis A, Greenberg PB, et al. optical coherence tomography findings following photodynamic therapy of choroidal neovascularisation. Am J Ophthalmol 2002;134:566-76.
17. Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic Bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Ophthalmology 2005;112:1035-47.
18. Talks J, Koshy Z, Chatzinikolas K. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Br J Ophthalmol 2007;91:600-1.
19. Coscas F, Coscas G, Souied E, et al. Optical coherence tomography identification of occult choroidal neovascularisation in age-related macular degeneration. Am J Ophthalmol 2007;144:592-9.
20. Menke MN, Feke GT. Assessment of effects of morphological changes related to age-related macular degeneration on optical coherence tomography retinal thickness measurements. Ophthalmic Surg Lasers Imaging 2005;36:310-14.
21. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2006;113:2054-65.
22. Alam S, Zawadzki RJ, Choi S, et al. Clinical application of rapid serial Fourier-Domain optical coherence tomography for macular imaging. Ophthalmology 2006;113:1425-31.
23. Schmid-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005;46:3393-402.
24. Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal Bevacizumab for the management of choroidal neovascularisation in age-related macular degeneration. Am J Ophthalmol 2006;142:1-9.
25. Submacular Surgery Trials Research Group. Histopathologic and ultrastructural features of surgically excised subfoveal and choroidal neovascular lesions: Submacular surgery trials report No. 7. Arch Ophthalmol 2005;123:914-21.